Cargando…

Medication persistence for psoriatic arthritis in a Brazilian real-world setting

AIM: To evaluate the persistence of biological (TNF inhibitor [anti-TNF]) and synthetic (conventional synthetic disease-modifying antirheumatic drugs [csDMARDs]) antirheumatic agents for psoriatic arthritis and their associated factors. METHODS: A historical cohort was developed. Persistence and ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro da Silva, Michael Ruberson, Ribeiro dos Santos, Jéssica Barreto, Maciel Almeida, Alessandra, Itria, Alexander, Maria Kakehasi, Adriana, Alvares Teodoro, Juliana, de Assis Acurcio, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391629/ https://www.ncbi.nlm.nih.gov/pubmed/30820348 http://dx.doi.org/10.4155/fsoa-2018-0101

Ejemplares similares

First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
por: da Silva, Michael Ruberson Ribeiro, et al.
Publicado: (2022)

Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil
por: Faria, Ronaldo José, et al.
Publicado: (2022)

Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System
por: de Souza, Elisa Neide Barbosa, et al.
Publicado: (2022)

Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study
por: Souza, Ana F., et al.
Publicado: (2021)

Adherence and persistence of subcutaneous biologics delivered through homecare services to a cohort of patients with rheumatoid arthritis
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2017)

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
por: Camelo, Ricardo Mesquita, et al.
Publicado: (2023)

Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study
por: Rezende Macedo do Nascimento, Renata Cristina, et al.
Publicado: (2020)

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
por: Alegre-Sancho, Juan José, et al.
Publicado: (2023)

Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System
por: Gargano, Ludmila Peres, et al.
Publicado: (2022)

Prevalence of eye disease in Brazilian patients with psoriatic arthritis
por: de Lima, Fernanda B. F., et al.
Publicado: (2012)

Access to medicines by patients of the primary health care in the Brazilian Unified Health System
por: Álvares, Juliana, et al.
Publicado: (2017)

Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: da Silva, Wânia Cristina, et al.
Publicado: (2018)

Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study
por: Gamonal, Shirley Braga Lima, et al.
Publicado: (2021)

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2023)

Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016)

Conceptions on pharmaceutical services in Brazilian primary health care
por: Costa, Ediná Alves, et al.
Publicado: (2017)

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2019)

Dezesseis Anos de Transplante Cardíaco em Coorte Aberta no Brasil: Análise de Sobrevivência de Pacientes em Uso de Imunossupressores
por: Freitas, Natália Cristina Cardoso, et al.
Publicado: (2021)

Treatment persistence of biologics among patients with psoriatic arthritis
por: Haddad, Amir, et al.
Publicado: (2021)

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
por: Haddad, Amir, et al.
Publicado: (2023)

Pharmaceutical services in the primary health care of the Brazilian Unified Health System: advances and challenges
por: Costa, Karen Sarmento, et al.
Publicado: (2017)

Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
por: Joven, Beatriz, et al.
Publicado: (2023)

Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS)
por: Costa, Karen Sarmento, et al.
Publicado: (2017)

Characterization of the institutionalization of pharmaceutical services in Brazilian primary health care
por: Souza, Gisélia Santana, et al.
Publicado: (2017)

Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2023)

Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
por: Nascimento, Guilherme Fagundes, et al.
Publicado: (2020)

Who should pay for the continuity of post-trial health care treatments?
por: Iunes, Roberto, et al.
Publicado: (2019)

Assessment of adiposity in psoriatic patients by dual energy X-ray absorptiometry compared to conventional methods
por: Diniz, Michelle dos Santos, et al.
Publicado: (2016)

Real-world burden of comorbidities in US patients with psoriatic arthritis
por: Shah, Kamal, et al.
Publicado: (2017)

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis
por: Svedbom, Axel, et al.
Publicado: (2017)

Psoriatic arthritis
por: Sankowski, Artur Jacek, et al.
Publicado: (2013)

Psoriatic Arthritis
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
por: Joven, Beatriz, et al.
Publicado: (2023)

Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study
por: Souza, Kathiaja Miranda, et al.
Publicado: (2020)

Patient satisfaction with pharmaceutical services in Brazilian primary health care
por: Soeiro, Orlando Mario, et al.
Publicado: (2017)

Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden
por: Geale, Kirk, et al.
Publicado: (2020)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

Management of pharmaceutical services in the Brazilian primary health care
por: Gerlack, Letícia Farias, et al.
Publicado: (2017)

New Insights on Juvenile Psoriatic Arthritis
por: Brunello, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ubneu0f028svtdlr4oqp3noho4